Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 3
1985 1
1986 1
1987 1
1989 2
1990 2
1991 2
1996 1
1997 3
1998 1
1999 1
2000 2
2001 9
2002 5
2003 2
2004 2
2006 5
2007 3
2008 5
2009 1
2010 2
2011 5
2012 2
2013 5
2014 8
2015 4
2016 9
2017 7
2018 4
2019 7
2020 2
2021 9
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

110 results
Results by year
Filters applied: . Clear all
Page 1
The Charcot foot in diabetes.
Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, Hartemann A, Game F, Jeffcoate W, Jirkovska A, Jude E, Morbach S, Morrison WB, Pinzur M, Pitocco D, Sanders L, Wukich DK, Uccioli L. Rogers LC, et al. Among authors: jirkovska a. J Am Podiatr Med Assoc. 2011 Sep-Oct;101(5):437-46. doi: 10.7547/1010437. J Am Podiatr Med Assoc. 2011. PMID: 21957276 Review.
Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo.
Kollárová-Brázdová P, Lenčová-Popelová O, Karabanovich G, Kocúrová-Lengvarská J, Kubeš J, Váňová N, Mazurová Y, Adamcová M, Jirkovská A, Holečková M, Šimůnek T, Štěrbová-Kovaříková P, Roh J, Štěrba M. Kollárová-Brázdová P, et al. Among authors: jirkovska a. Clin Sci (Lond). 2021 Aug 13;135(15):1897-1914. doi: 10.1042/CS20210311. Clin Sci (Lond). 2021. PMID: 34318878
Development of water-soluble prodrugs of the bisdioxopiperazine topoisomerase IIβ inhibitor ICRF-193 as potential cardioprotective agents against anthracycline cardiotoxicity.
Bavlovič Piskáčková H, Jansová H, Kubeš J, Karabanovich G, Váňová N, Kollárová-Brázdová P, Melnikova I, Jirkovská A, Lenčová-Popelová O, Chládek J, Roh J, Šimůnek T, Štěrba M, Štěrbová-Kovaříková P. Bavlovič Piskáčková H, et al. Among authors: jirkovska a. Sci Rep. 2021 Feb 24;11(1):4456. doi: 10.1038/s41598-021-83688-x. Sci Rep. 2021. PMID: 33627707 Free PMC article.
Stimulation TcPO2 Testing Improves Diagnosis of Peripheral Arterial Disease in Patients With Diabetic Foot.
Fejfarová V, Matuška J, Jude E, Piťhová P, Flekač M, Roztočil K, Wosková V, Dubský M, Jirkovská A, Bém R, Husáková J, Lánská V. Fejfarová V, et al. Among authors: jirkovska a. Front Endocrinol (Lausanne). 2021 Dec 10;12:744195. doi: 10.3389/fendo.2021.744195. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34956078 Free PMC article.
Structure-Activity Relationship Study of Dexrazoxane Analogues Reveals ICRF-193 as the Most Potent Bisdioxopiperazine against Anthracycline Toxicity to Cardiomyocytes Due to Its Strong Topoisomerase IIβ Interactions.
Jirkovská A, Karabanovich G, Kubeš J, Skalická V, Melnikova I, Korábečný J, Kučera T, Jirkovský E, Nováková L, Bavlovič Piskáčková H, Škoda J, Štěrba M, Austin CA, Šimůnek T, Roh J. Jirkovská A, et al. J Med Chem. 2021 Apr 8;64(7):3997-4019. doi: 10.1021/acs.jmedchem.0c02157. Epub 2021 Mar 22. J Med Chem. 2021. PMID: 33750129
110 results